Václav Němec

Václav Němec

SGC Frankfurt

Němec

Václav Němec

+49 (0)69 798-29914

Affiliations

Biography

Václav Němec studied Chemistry (BSc.) and later on also Organic Chemistry (MSc. and PhD.) at Masaryk University in Brno, Czech Republic. During his studies in Brno he was involved in several med-chem and chemical biology projects focusing for instance on development of novel kinase inhibitors (CLKs, CK1, ALKs) or inhibitors of Hedgehog signaling. He has spent 7 months in Manchester (UK) on a research stay in laboratories of Prof. David Procter, where he was working on the synthesis of natural product Phaeocaulising based on SmI2 mediated radical cascade reaction. Owing to Jean Marie Lehn scholarship, he spent also one month at EICB Bordeaux (France) in the research group of Prof. Frédéric Friscourt, where he was working on a chemo-enzymatic synthesis of poly-LacNAc chains for binding and study of lectins. In September 2020 he has joined the SGC node at Goethe University in Frankfurt where he is working on development of novel PROTACs and establishment of chemogenomic library.

2024

Development and Discovery of a Selective Degrader of Casein Kinases 1 δ/ε.

Haag A, Němec V, Janovská P, Bartošíková J, Adhikari B, Müller J, Schwalm MP, Čada Š, Ohmayer U, Daub H, Kim Y, Born F, Wolf E, Bryja V, Knapp S

J Med Chem. 2024-12-27 . .doi: 10.1021/acs.jmedchem.4c02201

PMID: 39729064

Discovery of Two Highly Selective Structurally Orthogonal Chemical Probes for Activin Receptor-like Kinases 1 and 2.

Němec V, Remeš M, Beňovský P, Böck MC, Šranková E, Wong JF, Cros J, Williams E, Tse LH, Smil D, Ensan D, Isaac MB, Al-Awar R, Gomolková R, Ursachi VC, Fafílek B, Kahounová Z, Víchová R, Vacek O, Berger BT, Wells CI, Corona CR, Vasta JD, Robers MB, Krejci P, Souček K, Bullock AN, Knapp S, Paruch K

J Med Chem. 2024-7-18 . .doi: 10.1021/acs.jmedchem.4c00629

PMID: 39023313

A C-Degron Structure-Based Approach for the Development of Ligands Targeting the E3 Ligase TRIM7.

Muñoz Sosa CJ, Lenz C, Hamann A, Farges F, Dopfer J, Krämer A, Cherkashyna V, Tarnovskiy A, Moroz YS, Proschak E, Němec V, Müller S, Saxena K, Knapp S

ACS Chem Biol. 2024-6-27 . .doi: 10.1021/acschembio.4c00301

PMID: 38934237

2022

PROTAC degraders as chemical probes for studying target biology and target validation.

Němec V, Schwalm MP, Müller S, Knapp S

Chem Soc Rev. 2022-8-25 . .doi: 10.1039/d2cs00478j

PMID: 36004812

2021

Highly selective inhibitors of protein kinases CLK and HIPK with the furo[3,2-b]pyridine core.

Němec V, Maier L, Berger BT, Chaikuad A, Drápela S, Souček K, Knapp S, Paruch K

Eur J Med Chem. 2021-2-18 . 215:113299 .doi: 10.1016/j.ejmech.2021.113299

PMID: 33636538

2018

Furo[3,2-b]pyridine: A Privileged Scaffold for Highly Selective Kinase Inhibitors and Effective Modulators of the Hedgehog Pathway.

Němec V, Hylsová M, Maier L, Flegel J, Sievers S, Ziegler S, Schroeder M, Berger BT, Chaikuad A, Valčíková B, Uldrijan S, Drápela S, Souček K, Waldmann H, Knapp S, Paruch K

Angew. Chem. Int. Ed. Engl.. 2018-12-20 . .doi: 10.1002/anie.201810312

PMID: 30569600